Jacob Van Naarden is listed in Lilly's 2025 Form 10-K as executive vice president, president of Lilly Oncology and head of corporate business development.
Title: Executive Vice President, President, Lilly Oncology, and Head of Corporate Business Development | Company: Eli Lilly